Current Report Filing (8-k)
August 13 2018 - 4:17PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
______________
FORM 8-K
______________
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): August 13, 2018 (August 13,
2018)
______________
MOLINA
HEALTHCARE, INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
1-31719
|
13-4204626
|
(State or other jurisdiction of
incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
______________
200 Oceangate, Suite 100, Long Beach, California 90802
|
(Address of principal executive offices)
|
Registrant’s
telephone number, including area code:
(562) 435-3666
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
⃞
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
⃞
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
⃞
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
⃞
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934
(§240.12b-2 of this chapter)
Emerging growth company
|
⃞
|
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
|
⃞
|
Item 1.02. Termination of a Material Definitive Agreement.
On August 13, 2018, Molina Healthcare, Inc. (the “Company”) terminated
the aggregate commitments under that certain Bridge Credit Agreement,
dated as of January 2, 2018 (the “Bridge Credit Agreement”), with
SunTrust Bank, Barclays Bank PLC, The Bank of Tokyo-Mitsubishi UFJ,
Ltd., Bank of America, N.A., and Morgan Stanley Senior Funding, Inc., as
Lenders, and SunTrust Bank, as Administrative Agent.
The Bridge Credit Agreement provided for a 364-day unsecured senior
bridge facility in an aggregate principal amount of up to $550.0 million
to be used to (i) satisfy conversions of the Company’s 1.125% Cash
Convertible Senior Notes due 2020 (the “1.125% Notes”), (ii) satisfy
and/or refinance indebtedness incurred to satisfy conversions of the
1.125% Notes, (iii) repay or refinance the Company’s existing revolving
credit facility, and (iv) pay fees and expenses in connection with the
foregoing (collectively, “Funding Purposes”). Subject to the
satisfaction of certain conditions, the remaining amount of any
borrowings was available to be used for general corporate purposes.
No amounts were borrowed by the Company pursuant to the Bridge Credit
Agreement and no early termination fees or penalties are payable by the
Company as a result of its termination of the Bridge Credit
Agreement. The decision to terminate the Bridge Credit Agreement was
based primarily on the Company’s determination that it no longer
required the bridge credit facility to satisfy the Funding Purposes.
Some of the lenders under the Bridge Credit Agreement (and their
respective subsidiaries or affiliates) have in the past provided, and
are currently providing, investment banking, underwriting, lending,
commercial banking, and other advisory services to the Company and its
subsidiaries. These parties have received, and may in the future
receive, customary compensation from the Company and its subsidiaries
for such services.
A full description of the Bridge Credit Agreement is set forth under
Item 1.01 on Form 8-K filed by the Company with the Securities and
Exchange Commission on January 2, 2018, which description is
incorporated herein by reference.
SIGNATURE
Pursuant to
the requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
|
MOLINA HEALTHCARE, INC.
|
|
|
|
|
|
|
Date:
|
August 13, 2018
|
|
By:
|
|
/s/ Jeff D. Barlow
|
|
|
|
|
|
Jeff D. Barlow
|
|
|
|
|
|
Chief Legal Officer and Secretary
|
Molina Healthcare (NYSE:MOH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Molina Healthcare (NYSE:MOH)
Historical Stock Chart
From Apr 2023 to Apr 2024